Trial Profile
A Phase I, Open Interaction Study Between Oral Doses of GLPG1837 and Single Doses of Midazolam in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs GLPG 1837 (Primary) ; Midazolam
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 22 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Oct 2015 New trial record